· 25/09/2022
MANTRA: evaluating the association between retinal sensitivity and retinal flow in AMD
· 22/05/2022наем
VELODROME: efficacy, safety and pharmacokinetics of ranibizumab 100 mg/ml through a PDS in patients with nDMAE
· 15/05/2022
TALON (Extension): efficacy and safety of brolucizumab 6 mg in a maximum interval dosing schedule of 20 weeks for patients with nDMAE
· 15/05/2022
GALE: evaluating the long-term safety and efficacy of intravitreal pegcetacoplan in patients with GA secondary to AMD
· 11/04/2022наем
IONIS: safety and efficacy of multiple doses of IONIS-FB-LRX
· 04/04/2022
Avonelle X: long-term safety and tolerability of the administration of intravitreal injections of Faricimab
· 15/02/2022наем
RADIS: Observational Study of Rare Retinal Pathologies
· 18/11/2020
Phase I/IIa study in subjects with Pigmentary Retinosis
· 18/11/2020
KODIAK: A phase II study in patients with the exudative form of AMD
· 18/11/2020наем
REVERS: Study using postbiotics in AMD patients
· 14/02/2020
Clinical trial OAKS-DERBY: efficacy and safety of pegcetacoplan in the treatment of geographic atrophy secondary to AMD
· 26/11/2019
TALON clinical trial: Efficacy and safety of brolacizumab in the treatment of exudative AMD
· 13/11/2019наем
Research project MICROBEYEOME
· 09/04/2019
LUCERNE clinical trial: efficacy and safety of FARICIMAB regarding aflibercept in the treatment of exudative age-related macular degeneration
· 10/05/2018
Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease